European Renal Association Published Nephrotic Syndrome Guidance
The new clinical review details 10 recommendations to improve diagnostic accuracy and reduce preventable patient complications.
Updated on Oct. 14, 2026 in Stroke
Live Poll
Do you trust that updated medical guidelines effectively reduce preventable complications for patients?
The European Renal Association has released 10 clinical recommendations for managing nephrotic syndrome. The guidance integrates immunologic biomarkers and kidney biopsy results to help physicians provide more individualized patient care.
Why it matters
Patients with nephrotic syndrome face significantly higher risks for serious health events compared to the general population. These standards aim to minimize preventable complications by providing clear protocols for diagnosis and supportive treatment.
The new guidance from the Immunonephrology Working Group includes five clinical actions and five specific warnings for practitioners. Clinicians are advised that up to 1 in 5 cases of adult-onset focal segmental glomerulosclerosis may have a genetic origin.
The players
European Renal Association
This is a non-profit organization dedicated to the study and treatment of kidney diseases through research, education, and the development of clinical standards.
Immunonephrology Working Group
This body operates under the European Renal Association to establish evidence-based guidance for treating immunological kidney disorders.
The details
The review emphasizes the use of antibody testing for phospholipase A2 receptors to identify membranous nephropathy, potentially avoiding invasive biopsies. Additionally, the guidelines mandate testing for latent infections like tuberculosis or hepatitis B before initiating immunosuppressive therapies.
Timeline
October 14, 2026: The review featuring 10 clinical recommendations was officially published.
The Big Picture
These guidelines follow the rigorous evidence-based frameworks established by the European Renal Association's Immunonephrology Working Group. This publication updates and formalizes the diagnostic protocols that nephrologists use to bridge gaps between genetic testing and traditional kidney biopsies.
Patients may see improved diagnostic accuracy as clinicians adopt new standards for antibody testing and infection screening. These guidelines prioritize blood pressure control and lipid monitoring to help reduce the elevated risk of cardiovascular events and blood clots.
The takeaway
Patients diagnosed with nephrotic syndrome should discuss these new clinical standards with their healthcare provider to ensure their treatment plan addresses all associated risk factors. Regular monitoring of blood pressure and lipids is essential for reducing the higher incidence of stroke and heart attack in this population.
Further reading
Learn more about kidney-related vascular risks in the Stroke section.
Source note: This article includes information reported by Medscape.
Live Poll
Do you trust that updated medical guidelines effectively reduce preventable complications for patients?
